Latest Articlesddd

Halozyme Announced Janssen Received U.S. FDA Approval of DARZALEX FASPRO®. See Also: IVERIC bio News

July 13, 2021 0

Halozyme Therapeutics Announced US FDA Approval for Janssen Biotech's DARZALEX FASPRO® Halozyme Therapeutics (HALO) announced that …

Companies Behind the Biotechnology Revolution

July 12, 2021 0

Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in …

Why Celldex Therapeutics Stock is Soaring

July 11, 2021 0

Celldex Therapeutics is Soaring Celldex Therapeutics (CLDX) stock soared following the firm’s announcement of updated data …

Important News and Results from Two Companies in the Prohost Portfolio

July 9, 2021 0

Important News and Results from Akero Therapeutics Akero Therapeutics (AKRO) announced that full results of the …

IVERIC bio Receives FDA Agreement Under an SPA for GATHER2 Phase 3 Clinical Trial of Zimura®

July 6, 2021 0

IVERIC bio GATHER2 Trial of Zimura® for Geographic Atrophy  IVERIC Bio (ISEE) announced that it received …

TRxADE HEALTH Subsidiary, Bonum Health, Signed a Telemedicine Service Distribution Deal with Big Y Pharmacy. See Also: Innate Pharma

July 1, 2021 0

TRxADE HEALTH Inc TRxADE HEALTH Inc (MEDS) is a health service IT company focused on digitalizing …

Intellia Therapeutics and Regeneron Pharmaceuticals: Yes, it is a Miracle!

June 29, 2021 0

Prohost Portfolio PLUS #6 Yes, it is a Miracle! Intellia Therapeutics and Regeneron Pharmaceuticals This miracle …

Vir Biotechnology: Promising Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 for Chronic HBV Infection  

June 25, 2021 0

Vir Biotechnology Announced Positive Safety Findings from its Ongoing Trials for Chronic HBV Vir Biotechnology (VIR) …

Halozyme Therapeutics Good News About Approvals. See Also: Arrowhead Pharmaceuticals Good Trial Results for Liver Diseases  

June 23, 2021 0

Halozyme Therapeutics Approvals for DARZALEX®SC Halozyme Therapeutics (HALO) announced that the European Commission (EC) has granted …

Blackstone Announces the Launch of a New Company with Intellia Therapeutics and Cellex Cell Professionals GmbH

June 22, 2021 0

Blackstone Life Sciences, Intellia Therapeutics and Cellex Cell Professionals New Company Blackstone (BX) announced that funds …

Auris Medical Holding Ltd has Encouraging Results Addressing the Unmet Needs of ATLL

June 21, 2021 0

Auris Medical Holding Ltd OligoPhoreTM Technology for ATLL Auris Medical Holding Ltd. (EARS) is a company …

An FDA Approval for Blueprint Medicines. See Also: An Important Presentation from IVERIC Bio

June 18, 2021 0

Inferior ways used to evaluate clinical-stage biotech firms are those that ignore the sciences, the technologies …

Gilead Sciences CAR-T Cell Yescarta Became the First and Only FDA Approved Treatment for Patients with Relapsed or Refractory Indolent Follicular Lymphoma

June 16, 2021 0

Gilead Sciences Yescarta for Relapsed or Refractory Indolent Follicula Lymphoma If Kite Pharma - a Gilead …

Jounce Therapeutics Inc Achieves First Milestone in Exclusive License Agreement with Gilead Sciences for JTX-1811

June 15, 2021 0

Jounce Therapeutics Inc: US FDA Cleared IND Application for JTX-1811 Targeting CCR8 Jounce Therapeutics Inc (JNCE) …

Veracyte Inc: Exciting News About nmCRPC Published Online

June 14, 2021 0

Veracyte Inc Decipher® Prostate Test Veracyte Inc (VCYT): New data that demonstrated the prognostic utility of …

The FDA Approval of Biogen’s Alzheimer’s Disease Drug and How Cassava Sciences Alzheimer’s Disease Drug Differs

June 12, 2021 0

Biogen Product Adulelm Approved for Alzheimer's Disease The latest news regarding Alzheimer’s disease is that of …

The U.S. FDA Approves Vertex Pharmaceuticals TRIKAFTA for Children with Cystic Fibrosis Aged 6 to 11 with Certain Mutations

June 9, 2021 0

Vertex Pharmaceuticals Receives FDA Approval for TRIKAFTA® Vertex Pharmaceuticals (VRTX) announced the U.S. FDA approved the …

The FDA Lifts the Clinical Holds on bluebird bio Gene Therapies in Clinical Trials

June 7, 2021 0

Clinical Holds on bluebird bio Gene Therapies were Lifted by the FDA The U.S. FDA has …

Intellia Therapeutics Gene Editing Product NTLA-2001 – A Dream on its Way to Becoming Reality

June 4, 2021 0

Focus on Intellia Therapeutics Upcoming Presentation for NTLA-2001 Data to offer insight into safety and pharmacodynamics …

BridgeBio Pharma Has Promising News

June 2, 2021 0

BridgeBio Pharma Granted Fast Track Designation for Encaleret BridgeBio Pharma (BBIO) announced the U.S. FDA granted …